GL1X · GenesisL1 explorer

Research workbench

Human ppargamma ligand binding dmain complexed with SB1453 in a covalent bonded form

Analyse Human ppargamma ligand binding dmain complexed with SB1453 in a covalent bonded… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5DVC
Type
protein
Length
279 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma; Nuclear receptor coactivator 1
EC
2.3.1.48
UniProt
P37231, Q15788
Ligands
T53
Pockets
2 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein26868% helix, 4% strandP37231
BNuclear receptor coactivator 1 (EC 2.3.1.48)protein1173% helix, 0% strandQ15788

Ligands and binding sites

  • T53 · N-[2-({3-[({4-[(4-methylpiperazin-1-yl)methyl]benzoyl}amino)methyl]benzyl}oxy)phenyl]-3-nitrobenzamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14080.810.8955T53
2630.280.7311empty

Interfaces

1 interface between chains.

  • A–B · 573 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5DVC · Human PPARgamma ligand binding dmain complexed with SB1453 in a covalent bonded form · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.